A 67-year-old man with poorly controlled diabetes mellitus and chronic kidney disease stage 4 presents with a 2-day history of fever, severe headache, confusion, and photophobia. Lumbar puncture shows: opening pressure 28 cmH2O, CSF glucose 2.1 mmol/L (serum glucose 8.2 mmol/L), protein 1.8 g/L, white cells 850/mm³ (90% polymorphs). Gram stain shows Gram-positive diplococci. He is started on IV ceftriaxone. What additional antimicrobial agent should be added to his treatment regimen?
Q172
A 52-year-old man from Zimbabwe presents with a 3-month history of cough, weight loss, and night sweats. Chest X-ray shows bilateral upper lobe cavitation. Three sputum samples are collected for TB investigation. Ziehl-Neelsen staining shows acid-fast bacilli. The laboratory reports that nucleic acid amplification testing (NAAT) will be performed. What is the primary purpose of NAAT in this clinical scenario?
Q173
A 26-year-old woman presents to the emergency department with a 24-hour history of fever, severe headache, photophobia, and neck stiffness. She develops a widespread non-blanching purpuric rash. Blood cultures are taken and empirical antibiotics are commenced. According to UK public health guidelines, within what timeframe must this case be notified to the local Health Protection Team?
Q174
A 34-year-old woman with pulmonary tuberculosis is currently receiving rifampicin, isoniazid, pyrazinamide, and ethambutol. Which of the following medication side effects requires routine monitoring with monthly ophthalmology assessments during the intensive phase of treatment?
Q175
A 48-year-old man from Bangladesh presents with a 2-month history of productive cough, fever, and weight loss. Chest X-ray shows bilateral upper zone infiltrates with cavitation. Sputum microscopy shows acid-fast bacilli. GeneXpert MTB/RIF assay detects Mycobacterium tuberculosis with rifampicin resistance. Culture subsequently confirms rifampicin and isoniazid resistance (MDR-TB), but sensitivity to fluoroquinolones and second-line injectables. What is the minimum recommended duration of treatment for this patient?
Q176
A 5-year-old girl presents with fever, headache, and neck stiffness. She is drowsy but rousable. Lumbar puncture shows: opening pressure 22 cmH₂O, white cells 800/mm³ (60% lymphocytes, 40% neutrophils), protein 1.2 g/L, glucose 3.1 mmol/L (plasma 5.8 mmol/L). Gram stain is negative. Bacterial culture is negative at 48 hours. Enterovirus PCR is positive. What is the most appropriate management?
Q177
A 35-year-old woman is diagnosed with latent tuberculosis infection (positive interferon-gamma release assay) during screening before starting adalimumab for Crohn's disease. Chest X-ray is normal. She has a history of isoniazid-induced hepatitis during previous TB prophylaxis 5 years ago (ALT peaked at 850 U/L). What is the most appropriate management?
Q178
A 72-year-old man with a prosthetic aortic valve presents with fever, confusion, and neck stiffness. Lumbar puncture shows: white cells 3,200/mm³ (90% neutrophils), protein 4.1 g/L, glucose 1.1 mmol/L (plasma 6.8 mmol/L), Gram stain shows Gram-positive cocci in chains. Blood cultures grow Streptococcus gallolyticus (formerly S. bovis). What additional investigation is most important?
Q179
A 44-year-old man from Somalia is diagnosed with pulmonary tuberculosis. Culture confirms Mycobacterium tuberculosis fully sensitive to first-line drugs. He has a BMI of 32 kg/m². After 2 months of rifampicin, isoniazid, pyrazinamide, and ethambutol, repeat sputum culture remains positive. What is the most likely explanation for treatment failure?
Q180
A 14-year-old boy presents with a 6-hour history of fever, severe headache, neck stiffness, and photophobia. Lumbar puncture shows: white cells 1,800/mm³ (80% neutrophils), protein 2.8 g/L, glucose 2.2 mmol/L (plasma 5.5 mmol/L). Gram stain is negative. PCR confirms Neisseria meningitidis serogroup W. He is treated successfully with intravenous ceftriaxone. Which prophylactic antibiotic should be given to his household contacts?
Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs
Question 171: A 67-year-old man with poorly controlled diabetes mellitus and chronic kidney disease stage 4 presents with a 2-day history of fever, severe headache, confusion, and photophobia. Lumbar puncture shows: opening pressure 28 cmH2O, CSF glucose 2.1 mmol/L (serum glucose 8.2 mmol/L), protein 1.8 g/L, white cells 850/mm³ (90% polymorphs). Gram stain shows Gram-positive diplococci. He is started on IV ceftriaxone. What additional antimicrobial agent should be added to his treatment regimen?
A. Vancomycin (Correct Answer)
B. Aciclovir
C. Gentamicin
D. Metronidazole
E. Ciprofloxacin
Explanation: ***Vancomycin***- The CSF findings (low glucose, high protein, polymorphonuclear pleocytosis, and **Gram-positive diplococci**) are highly suggestive of **bacterial meningitis**, specifically caused by **Streptococcus pneumoniae**.- In older patients (>=50 years) or those with comorbidities (like poorly controlled diabetes and CKD) or in areas with high rates of **penicillin-resistant *S. pneumoniae***, **vancomycin** should be added empirically to a third-generation cephalosporin (like ceftriaxone) to ensure adequate coverage until antibiotic sensitivities are known.*Aciclovir*- This is an **antiviral agent** specifically used for **herpes simplex encephalitis** (HSE), which typically presents with different CSF profiles (e.g., lymphocytic pleocytosis) and clinical features (e.g., focal neurological deficits).- The presence of **Gram-positive diplococci** on CSF Gram stain strongly indicates a bacterial, not viral, etiology for the meningitis.*Gentamicin*- This is an **aminoglycoside antibiotic** primarily active against **Gram-negative bacteria** and has poor **blood-brain barrier penetration** in adults, making it unsuitable for meningitis treatment.- It is not indicated for empirical therapy of community-acquired bacterial meningitis and would not cover the identified **Gram-positive diplococci** effectively in the CNS.*Metronidazole*- Metronidazole is primarily effective against **anaerobic bacteria** and some protozoa.- While anaerobes can cause CNS infections (e.g., brain abscesses), Gram-positive diplococci are typically aerobic or facultative anaerobic, and metronidazole is not a standard empirical treatment for **pneumococcal meningitis**.*Ciprofloxacin*- Ciprofloxacin is a **fluoroquinolone** with broad-spectrum activity, but it is not a first-line empirical agent for **bacterial meningitis** in this context.- It does not provide superior or essential added coverage for **resistant *S. pneumoniae*** compared to vancomycin when combined with ceftriaxone for this high-risk patient.
Question 172: A 52-year-old man from Zimbabwe presents with a 3-month history of cough, weight loss, and night sweats. Chest X-ray shows bilateral upper lobe cavitation. Three sputum samples are collected for TB investigation. Ziehl-Neelsen staining shows acid-fast bacilli. The laboratory reports that nucleic acid amplification testing (NAAT) will be performed. What is the primary purpose of NAAT in this clinical scenario?
A. To determine the drug susceptibility profile of the organism
B. To differentiate Mycobacterium tuberculosis from non-tuberculous mycobacteria (Correct Answer)
C. To quantify the bacterial load for monitoring treatment response
D. To identify specific genetic mutations associated with virulence
E. To determine whether the patient has latent or active infection
Explanation: ***To differentiate Mycobacterium tuberculosis from non-tuberculous mycobacteria***- While **Ziehl-Neelsen staining** confirms the presence of **acid-fast bacilli (AFB)**, it cannot distinguish between **M. tuberculosis complex** and **non-tuberculous mycobacteria (NTM)**.- **NAAT** provides rapid, highly sensitive **species identification** within hours, allowing for immediate confirmation of TB before **culture results** (which take weeks) are available.*To determine the drug susceptibility profile of the organism*- Although some **NAAT assays** (like Xpert MTB/RIF) can detect **rifampicin resistance**, the primary diagnostic purpose in this scenario, following AFB smear, is **species confirmation**.- Comprehensive **drug susceptibility testing (DST)** often still relies on **phenotypic culture-based methods** to cover a full range of anti-TB drugs.*To quantify the bacterial load for monitoring treatment response*- **NAAT** is a qualitative tool used for initial diagnosis, detecting the presence of bacterial DNA; it can remain positive due to **non-viable DNA** even after successful treatment.- **Sputum smear microscopy** and **culture conversion** are the standard methods for monitoring a patient's **response to therapy** and assessing bacterial load.*To identify specific genetic mutations associated with virulence*- **NAAT** targets specific conserved DNA sequences for **species identification** rather than evaluating **virulence factors** or pathogenicity genes.- Understanding **virulence** is generally a clinical or research focus and does not typically guide the standard diagnostic algorithm for **active TB**.*To determine whether the patient has latent or active infection*- The diagnosis of **active infection** is already strongly suggested by the clinical symptoms (**cough, weight loss, night sweats**), **bilateral upper lobe cavitation** on CXR, and the positive **AFB smear**.- **NAAT** identifies the pathogen in clinical samples of symptomatic patients, while tests like **IGRA** or **Mantoux tests** are used for screening **latent TB infection**.
Question 173: A 26-year-old woman presents to the emergency department with a 24-hour history of fever, severe headache, photophobia, and neck stiffness. She develops a widespread non-blanching purpuric rash. Blood cultures are taken and empirical antibiotics are commenced. According to UK public health guidelines, within what timeframe must this case be notified to the local Health Protection Team?
A. Within 24 hours by telephone and in writing within 3 days (Correct Answer)
B. Within 3 days by telephone or in writing
C. Immediately by telephone followed by written notification within 24 hours
D. Within 48 hours by telephone
E. Within 7 days in writing only
Explanation: ***Within 24 hours by telephone and in writing within 3 days*** - **Meningococcal disease**, presenting with a purpuric rash and meningeal signs, is a **Category 1 notifiable disease** in the UK, requiring urgent public health action. - UK public health guidelines (e.g., Health Protection Regulations 2010) mandate **initial oral/telephone notification** to the local Health Protection Team within **24 hours** to facilitate rapid contact tracing and chemoprophylaxis, followed by **formal written notification** within **3 days**. *Within 3 days by telephone or in writing* - This timeframe is **too slow** for highly infectious and severe conditions like suspected meningococcal septicaemia, which necessitate immediate intervention. - While written notification within 3 days is correct, it **must be preceded** by an urgent verbal report within 24 hours. *Immediately by telephone followed by written notification within 24 hours* - While an immediate telephone call is clinically best practice for such severe cases, the **formal statutory deadline** for the written notification is **3 days**, not 24 hours. - This option incorrectly states the official timeframe for the **written component** according to public health regulations. *Within 48 hours by telephone* - A **48-hour delay** for telephone notification is not compliant with guidelines for diseases requiring immediate public health response to prevent further spread. - This option also **omits the requirement** for a subsequent written notification, which is a mandatory part of the reporting process. *Within 7 days in writing only* - **Written-only notification** is reserved for less urgent notifiable diseases that do not pose an immediate public health threat requiring rapid action. - A **7-day delay** for a serious, highly transmissible infection like meningococcal disease would be entirely inappropriate and **compromise public safety**.
Question 174: A 34-year-old woman with pulmonary tuberculosis is currently receiving rifampicin, isoniazid, pyrazinamide, and ethambutol. Which of the following medication side effects requires routine monitoring with monthly ophthalmology assessments during the intensive phase of treatment?
A. Rifampicin-induced optic neuritis
B. Isoniazid-induced peripheral neuropathy affecting vision
C. Pyrazinamide-induced colour vision disturbance
D. Ethambutol-induced optic neuropathy (Correct Answer)
E. Rifampicin-induced uveitis
Explanation: ***Ethambutol-induced optic neuropathy***
- **Ethambutol** is well-known for causing dose-dependent **optic neuropathy**, which manifests as decreased visual acuity and **red-green color blindness**.
- Routine monthly monitoring of **visual acuity** and color perception is mandatory because the toxicity is often reversible if the drug is discontinued immediately.
*Rifampicin-induced optic neuritis*
- **Rifampicin** typically causes harmless **orange discoloration** of body fluids and potential hepatotoxicity rather than nerve inflammation.
- Optic neuritis is not a recognized side effect of rifampicin, making regular ophthalmic screening for this drug unnecessary.
*Isoniazid-induced peripheral neuropathy affecting vision*
- **Isoniazid** (INH) commonly causes **peripheral neuropathy** due to competitive inhibition of **pyridoxine (Vitamin B6)**, primarily affecting the limbs.
- Vision loss is not a standard presentation of INH-induced peripheral neuropathy; prevention involves co-administration of **pyridoxine supplementation**.
*Pyrazinamide-induced colour vision disturbance*
- **Pyrazinamide** is primarily associated with **hyperuricemia** (which may trigger gout) and potential **hepatotoxicity**.
- It has no known clinical association with **color vision disturbances** or other ophthalmic toxicities.
*Rifampicin-induced uveitis*
- While **rifabutin** (a related drug) is known to cause **uveitis**, **rifampicin** does not typically cause intraocular inflammation.
- Monitoring for uveitis is not a standard requirement for patients undergoing the standard **RIPE** regimen for pulmonary tuberculosis.
Question 175: A 48-year-old man from Bangladesh presents with a 2-month history of productive cough, fever, and weight loss. Chest X-ray shows bilateral upper zone infiltrates with cavitation. Sputum microscopy shows acid-fast bacilli. GeneXpert MTB/RIF assay detects Mycobacterium tuberculosis with rifampicin resistance. Culture subsequently confirms rifampicin and isoniazid resistance (MDR-TB), but sensitivity to fluoroquinolones and second-line injectables. What is the minimum recommended duration of treatment for this patient?
A. 9 months total with at least 5 months after culture conversion
B. 12 months total with at least 6 months after culture conversion
C. 18 months total with at least 12 months after culture conversion (Correct Answer)
D. 20 months total with at least 16 months after culture conversion
E. 24 months with at least 18 months after culture conversion
Explanation: ***18 months total with at least 12 months after culture conversion***- For traditional individualized **MDR-TB** regimens, the standard treatment duration is a minimum of **18 months**, ensuring sufficient time to prevent relapse.- Monitoring requires at least **12 months** of therapy following the first documented negative culture (**culture conversion**) to ensure the eradication of dormant bacilli, especially in patients with **cavitary disease**.*9 months total with at least 5 months after culture conversion*- This describes the **shorter MDR-TB regimen** (9-11 months), which is suitable for patients without **extensive disease** or specific resistance patterns.- The presence of **bilateral cavitation** in this patient indicates extensive disease, making them ineligible for the shorter regimen.*12 months total with at least 6 months after culture conversion*- This duration is insufficient for the management of **multidrug-resistant TB** and does not align with established **WHO guidelines** for either the shorter or longer regimens.- A 12-month course is generally not a recognized standard for the total duration of **MDR-TB** treatment, particularly for cases with **cavitary lesions**.*20 months total with at least 16 months after culture conversion*- While some older guidelines or specific complex cases might extend treatment to **20 months**, the current minimum recommended duration for the longer individualized regimen is **18 months**.- A requirement of **16 months post-culture conversion** is longer than the standard 12-month post-conversion requirement for most MDR-TB cases, even in the longer regimen.*24 months with at least 18 months after culture conversion*- This extended duration is typically reserved for **Extensively Drug-Resistant TB (XDR-TB)** or cases with extremely poor clinical response or very severe, extensive lung damage.- The patient's TB is sensitive to **fluoroquinolones** and second-line injectables, meaning it is **MDR-TB**, not XDR-TB, making 24 months an overestimation for the minimum duration.
Question 176: A 5-year-old girl presents with fever, headache, and neck stiffness. She is drowsy but rousable. Lumbar puncture shows: opening pressure 22 cmH₂O, white cells 800/mm³ (60% lymphocytes, 40% neutrophils), protein 1.2 g/L, glucose 3.1 mmol/L (plasma 5.8 mmol/L). Gram stain is negative. Bacterial culture is negative at 48 hours. Enterovirus PCR is positive. What is the most appropriate management?
A. Continue intravenous antibiotics for 7 days and add aciclovir
B. Stop all antimicrobials and provide supportive care (Correct Answer)
C. Continue intravenous antibiotics until bacterial culture negative at 5 days
D. Stop antibiotics but continue aciclovir for 14 days
E. Stop antibiotics, start pleconaril for enteroviral meningitis
Explanation: ***Stop all antimicrobials and provide supportive care***
- The patient has confirmed **Enterovirus meningitis** based on the positive PCR, negative Gram stain, and negative bacterial cultures at 48 hours.
- **Supportive care** including hydration and analgesia is the standard of care as viral meningitis is typically self-limiting with an excellent prognosis.
*Continue intravenous antibiotics for 7 days and add aciclovir*
- Extended **antibiotic therapy** is unnecessary once bacterial meningitis is ruled out by negative 48-hour cultures and a positive viral PCR.
- **Aciclovir** is used for Herpes Simplex Virus (HSV) encephalitis, not for enteroviral infections, and is not indicated here.
*Continue intravenous antibiotics until bacterial culture negative at 5 days*
- Standard practice allows for the cessation of empirical antibiotics if cultures remain negative at **48 hours** in a clinically stable patient with a viral diagnosis.
- Unnecessary antibiotic use increases the risk of **drug side effects** and promotes **antimicrobial resistance**.
*Stop antibiotics but continue aciclovir for 14 days*
- While stopping antibiotics is correct, there is no clinical or laboratory evidence (such as temporal lobe changes or positive HSV PCR) to justify **aciclovir**.
- **Enteroviruses** do not respond to aciclovir, making its continuation ineffective and potentially nephrotoxic.
*Stop antibiotics, start pleconaril for enteroviral meningitis*
- **Pleconaril** is not routinely recommended or licensed in many regions for standard enteroviral meningitis cases.
- Management of this condition remains primarily **symptomatic**, with antivirals reserved only for severe complications or immunocompromised patients.
Question 177: A 35-year-old woman is diagnosed with latent tuberculosis infection (positive interferon-gamma release assay) during screening before starting adalimumab for Crohn's disease. Chest X-ray is normal. She has a history of isoniazid-induced hepatitis during previous TB prophylaxis 5 years ago (ALT peaked at 850 U/L). What is the most appropriate management?
A. Proceed with adalimumab without treating latent TB, as previous prophylaxis was partially completed
B. Treat with rifampicin monotherapy for 4 months, then start adalimumab (Correct Answer)
C. Treat with isoniazid for 6 months with weekly monitoring of liver function
D. No treatment for latent TB is needed if chest X-ray remains normal
E. Treat with rifampicin plus isoniazid for 3 months, then start adalimumab
Explanation: ***Treat with rifampicin monotherapy for 4 months, then start adalimumab***- **Rifampicin monotherapy** for 4 months is the preferred alternative for **latent TB infection (LTBI)** when isoniazid is contraindicated due to previous severe **hepatotoxicity**.- Treating LTBI is mandatory before initiating **TNF-alpha inhibitors** like adalimumab, as these biologics significantly increase the risk of TB **reactivation**.*Proceed with adalimumab without treating latent TB, as previous prophylaxis was partially completed*- TNF-alpha inhibitors carry a high risk of converting latent TB to **active disease**; therapy must not be started until LTBI is addressed.- Previous **prophylaxis was aborted** due to toxicity, meaning the patient remains at risk and requires a full alternative course.*Treat with isoniazid for 6 months with weekly monitoring of liver function*- Re-challenging with isoniazid is contraindicated after **severe drug-induced liver injury** (ALT 850 U/L is >15x the upper limit of normal).- Continuing isoniazid despite a history of **isoniazid-induced hepatitis** puts the patient at risk for **acute liver failure**.*No treatment for latent TB is needed if chest X-ray remains normal*- A **normal chest X-ray** is expected in latent TB; it does not rule out the presence of dormant bacilli that can reactivate under **immunosuppression**.- A positive **IGRA (Interferon-Gamma Release Assay)** confirms LTBI, necessitating treatment regardless of static imaging findings before starting biologics.*Treat with rifampicin plus isoniazid for 3 months, then start adalimumab*- Although a 3-month combination is a standard regimen, it is unsuitable here because it still contains **isoniazid**.- The patient's history of **life-threatening hepatotoxicity** requires a strictly **isoniazid-free** regimen to ensure safety.
Question 178: A 72-year-old man with a prosthetic aortic valve presents with fever, confusion, and neck stiffness. Lumbar puncture shows: white cells 3,200/mm³ (90% neutrophils), protein 4.1 g/L, glucose 1.1 mmol/L (plasma 6.8 mmol/L), Gram stain shows Gram-positive cocci in chains. Blood cultures grow Streptococcus gallolyticus (formerly S. bovis). What additional investigation is most important?
A. Echocardiography to assess for endocarditis
B. CT chest to exclude bronchogenic carcinoma
C. Colonoscopy (Correct Answer)
D. Bone marrow biopsy
E. Upper GI endoscopy
Explanation: ***Colonoscopy***
- Infection with **Streptococcus gallolyticus** (formerly **S. bovis**) is strongly associated with underlying **colorectal malignancy** or large adenomatous polyps.
- Current guidelines mandate a **colonoscopy** in any patient with bacteremia or meningitis caused by this organism to screen for occult **colon cancer**.
*Echocardiography to assess for endocarditis*
- While **S. gallolyticus** is a common cause of **infective endocarditis**, especially in patients with prosthetic valves, this investigation is often part of the initial septic workup rather than the most distinct "additional" step linked to this specific bacteria.
- Identifying endocarditis manages the current infection, but **colonoscopy** is critical for detecting the underlying source and potentially life-threatening malignancy.
*CT chest to exclude bronchogenic carcinoma*
- There is no clinical or microbiological association between **Streptococcus gallolyticus** and **bronchogenic carcinoma**.
- This investigation would not be a routine response to **Gram-positive cocci** meningitis or bacteremia absent specific pulmonary symptoms.
*Bone marrow biopsy*
- **Bone marrow biopsy** is used for investigating hematological malignancies or unexplained cytopenias, which are not indicated by this presentation.
- It does not assist in identifying the source of an **S. gallolyticus** infection, which is localized to the gastrointestinal tract.
*Upper GI endoscopy*
- Although the organism is of GI origin, the specific association is with **colonic pathology** rather than gastric or esophageal conditions.
- An **upper GI endoscopy** (OGD) would be significantly less likely than a **colonoscopy** to yield a relevant diagnostic finding for this patient.
Question 179: A 44-year-old man from Somalia is diagnosed with pulmonary tuberculosis. Culture confirms Mycobacterium tuberculosis fully sensitive to first-line drugs. He has a BMI of 32 kg/m². After 2 months of rifampicin, isoniazid, pyrazinamide, and ethambutol, repeat sputum culture remains positive. What is the most likely explanation for treatment failure?
A. Development of acquired drug resistance during treatment
B. Inadequate drug dosing due to obesity
C. Non-adherence to treatment (Correct Answer)
D. Malabsorption of oral medications
E. Presence of HIV co-infection
Explanation: ***Non-adherence to treatment*** - **Non-adherence** is the most common cause of treatment failure and persistent positive cultures in patients undergoing therapy for **drug-sensitive tuberculosis**. - TB therapy involves a high **pill burden** and long duration, which frequently leads to poor compliance once the patient begins to feel clinically better. *Development of acquired drug resistance during treatment* - While possible, **acquired resistance** typically occurs as a secondary consequence of irregular self-administration or **non-adherence**. - It is less likely than simple non-adherence to be the *initial* explanation for a positive culture at the 2-month mark when the strain was initially **fully sensitive**. *Inadequate drug dosing due to obesity* - Standard **weight-band dosing** strategies for TB are designed to provide therapeutic levels even in patients with a higher **BMI**. - Although obesity can alter the volume of distribution, it is rarely the primary cause of complete **treatment failure** if the patient is taking the medication regularly. *Malabsorption of oral medications* - **Malabsorption** is a rare cause of failure and is usually associated with underlying gastrointestinal disorders like **Crohn's disease** or advanced **HIV/AIDS**. - This should only be considered after **adherence** has been strictly verified through **Directly Observed Therapy (DOT)**. *Presence of HIV co-infection* - While **HIV co-infection** can complicate the clinical course and increase the risk of disseminated disease, it does not inherently prevent **sputum conversion** if medications are taken correctly. - In the absence of other symptoms of **immunosuppression**, it is statistically less likely to cause a positive 2-month culture than patient non-compliance.
Question 180: A 14-year-old boy presents with a 6-hour history of fever, severe headache, neck stiffness, and photophobia. Lumbar puncture shows: white cells 1,800/mm³ (80% neutrophils), protein 2.8 g/L, glucose 2.2 mmol/L (plasma 5.5 mmol/L). Gram stain is negative. PCR confirms Neisseria meningitidis serogroup W. He is treated successfully with intravenous ceftriaxone. Which prophylactic antibiotic should be given to his household contacts?
A. No prophylaxis needed as he has already received ceftriaxone
B. Oral rifampicin 600mg twice daily for 2 days
C. Oral ciprofloxacin 500mg single dose (Correct Answer)
D. Intramuscular ceftriaxone 250mg single dose
E. Oral azithromycin 500mg single dose
Explanation: ***Oral ciprofloxacin 500mg single dose***
- **Ciprofloxacin** is a highly effective and generally well-tolerated agent for **meningococcal chemoprophylaxis** in adults and children over 12, given as a **single oral dose**.
- Its efficacy stems from excellent penetration into the **nasopharyngeal mucosa**, where *Neisseria meningitidis* colonizes, leading to rapid eradication of the carrier state and reduced transmission risk.
*No prophylaxis needed as he has already received ceftriaxone*
- The patient's treatment with **ceftriaxone** targets the systemic infection but does not reliably eradicate **nasopharyngeal carriage** of *Neisseria meningitidis* in the treated individual or prevent transmission to close contacts.
- **Household contacts** are at significantly increased risk of developing **meningococcal disease** due to close exposure to respiratory droplets from the index case, necessitating prompt **chemoprophylaxis**.
*Oral rifampicin 600mg twice daily for 2 days*
- **Rifampicin** is an effective prophylactic agent but requires a **multi-dose regimen** (typically 4 doses over 2 days), which can lead to lower compliance compared to single-dose options.
- It has significant drug interactions, including with **oral contraceptives**, and can cause **red-orange discoloration** of urine and tears, making it less preferred as a first-line agent where single-dose options are available.
*Intramuscular ceftriaxone 250mg single dose*
- **Intramuscular ceftriaxone** is an effective single-dose prophylactic option, particularly suitable for **pregnant women** and young children (under 12 years) for whom oral ciprofloxacin is contraindicated.
- However, for routine prophylaxis in healthy adults and adolescents, the **oral route** is preferred over an invasive **intramuscular injection** due to convenience and patient preference.
*Oral azithromycin 500mg single dose*
- **Azithromycin** is not a recommended agent for **meningococcal chemoprophylaxis** according to major guidelines (e.g., UKHSA, CDC), as there is insufficient evidence for its efficacy in eradicating *Neisseria meningitidis* carriage.
- While a macrolide, its role in prophylaxis for **invasive meningococcal disease** is not established, unlike for other bacterial infections such as pertussis or chlamydia.
